We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+2.6%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.34B
AUM Growth
+$209M
Cap. Flow
+$157M
Cap. Flow %
4.72%
Top 10 Hldgs %
12.01%
Holding
1,564
New
189
Increased
576
Reduced
529
Closed
163

Sector Composition

Rank Sector Weight
1 Energy 11.94%
2 Healthcare 10.62%
3 Industrials 9.8%
4 Technology 9.43%
5 Financials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LTM
76
DELISTED
LIFE TIME FITNESS INC
LTM
$9.24M 0.28%
192,045
+3,375
+2% +$154K
ORLY icon
77
O'Reilly Automotive
ORLY
$72.4B
$9.2M 0.28%
930,270
+330
+0% +$3.15K
LOW icon
78
Lowe's Companies
LOW
$118B
$9.07M 0.27%
185,587
-12,689
-6% -$612K
WFC icon
79
Wells Fargo
WFC
$258B
$8.96M 0.27%
180,231
-4,465
-2% -$208K
KO icon
80
Coca-Cola
KO
$381B
$8.88M 0.27%
229,651
+5,143
+2% +$199K
IGIB icon
81
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
$8.86M 0.27%
162,542
-3,226
-2% -$176K
IYW icon
82
iShares US Technology ETF
IYW
$23.5B
$8.83M 0.26%
387,708
+1,856
+0.5% +$41.4K
D icon
83
Dominion Energy
D
$61.3B
$8.77M 0.26%
123,579
+13,120
+12% +$896K
BND icon
84
Vanguard Total Bond Market
BND
$158B
$8.75M 0.26%
107,777
-990
-0.9% -$80.2K
ABBV icon
85
AbbVie
ABBV
$455B
$8.68M 0.26%
168,851
-12,910
-7% -$652K
KKR icon
86
KKR & Co
KKR
$90.7B
$8.63M 0.26%
377,897
-15,513
-4% -$376K
PXD
87
DELISTED
Pioneer Natural Resource Co.
PXD
$8.63M 0.26%
46,089
-71
-0.2% -$13K
HON icon
88
Honeywell
HON
$76.7B
$8.61M 0.26%
103,299
+38,669
+60% +$3.2M
TMO icon
89
Thermo Fisher Scientific
TMO
$214B
$8.59M 0.26%
71,474
+4,306
+6% +$512K
RTX icon
90
RTX Corp
RTX
$289B
$8.47M 0.25%
115,201
+957
+0.8% +$68.8K
VBR icon
91
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.2B
$8.46M 0.25%
84,040
+1,281
+2% +$125K
WM icon
92
Waste Management
WM
$90.9B
$8.41M 0.25%
199,862
-6,902
-3% -$289K
SLB icon
93
SLB Ltd
SLB
$72.6B
$8.25M 0.25%
84,629
-9,213
-10% -$833K
UMBF icon
94
UMB Financial
UMBF
$11.1B
$8.11M 0.24%
125,320
-45
-0% -$2.81K
HYG icon
95
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$8.06M 0.24%
85,407
+3,015
+4% +$283K
DBEF icon
96
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.23B
$8.03M 0.24%
+296,106
New +$7.95M
LLY icon
97
Eli Lilly
LLY
$1.03T
$7.97M 0.24%
135,422
+5,269
+4% +$294K
TEVA icon
98
Teva Pharmaceuticals
TEVA
$41.2B
$7.96M 0.24%
150,532
+11,068
+8% +$512K
VFC icon
99
VF Corp
VFC
$5.87B
$7.85M 0.24%
134,721
-25,309
-16% -$1.43M
DIS icon
100
Walt Disney
DIS
$167B
$7.8M 0.23%
97,390
+4,726
+5% +$366K

Similar funds

Oppenheimer & Co's Q1 2014 Portfolio in Review

As of Q1 2014, Oppenheimer & Co held 1,564 positions worth $3.34B, up 6.7% from $3.13B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co deployed $157M of net new capital in Q1 2014, opening 189 new positions and adding to 576 existing holdings. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 12% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Vanguard Dividend Appreciation ETF, an estimated $7.79M trimmed.

  • Oppenheimer & Co's largest Q1 2014 buy was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.
  • Oppenheimer & Co added most to Monsanto Co in Q1 2014, an estimated $30M increase.
  • Oppenheimer & Co's biggest Q1 2014 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $7.79M.
  • Oppenheimer & Co fully exited TetraLogic Pharmaceuticals Corporation in Q1 2014, selling an estimated $10.2M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.34B portfolio in Q1 2014.
  • Oppenheimer & Co opened 189 new positions and closed 163 in Q1 2014.
  • Oppenheimer & Co's portfolio value rose 6.7% quarter-over-quarter to $3.34B.

Based on Oppenheimer & Co's 13F filing for Q1 2014, filed 9 May 2014.